Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1044 Neoplasms 876 Prostatic Neoplasms 507 Lung Neoplasms 422 Colorectal Neoplasms 358 Motor Activity 220 Head and Neck Neoplasms 194 Uterine Cervical Neoplasms 190 Carcinoma, Non-Small-Cell Lung 180 Brain Neoplasms 173 Pancreatic Neoplasms 160 Ovarian Neoplasms 138 Colonic Neoplasms 137 Carcinoma, Hepatocellular 136 Anxiety Disorders 124 Rectal Neoplasms 117 Hematologic Neoplasms 115 Multiple Myeloma 106 Stomach Neoplasms 103 Neoplasm Metastasis 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Depression 93 Melanoma 92 Urinary Bladder Neoplasms 88 Pain 87 Endometrial Neoplasms 86 Glioblastoma 84 Disease 83 Lymphoma 81 Sarcoma 78

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × High-Risk Cancer × 1 year × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡